122 related articles for article (PubMed ID: 33737089)
1. Prenatal MAM treatment altered fear conditioning following social isolation: Relevance to schizophrenia.
Bilecki W; Latusz J; Gawlińska K; Chmelova M; Maćkowiak M
Behav Brain Res; 2021 May; 406():113231. PubMed ID: 33737089
[TBL] [Abstract][Full Text] [Related]
2. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
[TBL] [Abstract][Full Text] [Related]
3. Adolescent social isolation affects parvalbumin expression in the medial prefrontal cortex in the MAM-E17 model of schizophrenia.
Maćkowiak M; Latusz J; Głowacka U; Bator E; Bilecki W
Metab Brain Dis; 2019 Feb; 34(1):341-352. PubMed ID: 30519836
[TBL] [Abstract][Full Text] [Related]
4. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
Gill KM; Miller SA; Grace AA
Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia.
Bilecki W; Wawrzczak-Bargieła A; Majcher-Maślanka I; Chmelova M; Maćkowiak M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445411
[TBL] [Abstract][Full Text] [Related]
6. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function.
Chalkiadaki K; Velli A; Kyriazidis E; Stavroulaki V; Vouvoutsis V; Chatzaki E; Aivaliotis M; Sidiropoulou K
Neuropharmacology; 2019 Jan; 144():193-207. PubMed ID: 30366002
[TBL] [Abstract][Full Text] [Related]
7. Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex.
Maćkowiak M; Bator E; Latusz J; Mordalska P; Wędzony K
Eur Neuropsychopharmacol; 2014 Feb; 24(2):271-89. PubMed ID: 23932495
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
9. Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia.
Bator E; Latusz J; Wędzony K; Maćkowiak M
Eur Neuropsychopharmacol; 2018 Jan; 28(1):97-108. PubMed ID: 29174863
[TBL] [Abstract][Full Text] [Related]
10. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
O'Reilly KC; Perica MI; Fenton AA
Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
[TBL] [Abstract][Full Text] [Related]
11. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.
Hradetzky E; Sanderson TM; Tsang TM; Sherwood JL; Fitzjohn SM; Lakics V; Malik N; Schoeffmann S; O'Neill MJ; Cheng TM; Harris LW; Rahmoune H; Guest PC; Sher E; Collingridge GL; Holmes E; Tricklebank MD; Bahn S
Neuropsychopharmacology; 2012 Jan; 37(2):364-77. PubMed ID: 21956444
[TBL] [Abstract][Full Text] [Related]
12. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
[TBL] [Abstract][Full Text] [Related]
13. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity.
Uliana DL; Resstel LBM; Grace AA
Neuropsychopharmacology; 2018 Nov; 43(12):2459-2467. PubMed ID: 29973655
[TBL] [Abstract][Full Text] [Related]
14. Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
Featherstone RE; Rizos Z; Nobrega JN; Kapur S; Fletcher PJ
Neuropsychopharmacology; 2007 Feb; 32(2):483-92. PubMed ID: 17035930
[TBL] [Abstract][Full Text] [Related]
15. Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17.
Léna I; Chessel A; Le Pen G; Krebs MO; Garcia R
Psychopharmacology (Berl); 2007 Jun; 192(3):373-83. PubMed ID: 17279373
[TBL] [Abstract][Full Text] [Related]
16. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.
Potasiewicz A; Holuj M; Litwa E; Gzielo K; Socha L; Popik P; Nikiforuk A
Neuropharmacology; 2020 Jun; 170():108040. PubMed ID: 32165218
[TBL] [Abstract][Full Text] [Related]
17. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
[TBL] [Abstract][Full Text] [Related]
18. The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex: An Editorial Highlight for 'Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia' on page 320.
Zhu X; Gomes FV; Grace AA
J Neurochem; 2017 Nov; 143(3):264-267. PubMed ID: 28872674
[TBL] [Abstract][Full Text] [Related]
19. Effects of prenatal methylazoxymethanol acetate (MAM) treatment in rats on water maze performance.
Leng A; Jongen-Rêlo AL; Pothuizen HH; Feldon J
Behav Brain Res; 2005 Jun; 161(2):291-8. PubMed ID: 15922056
[TBL] [Abstract][Full Text] [Related]
20. Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.
Du Y; Grace AA
Neuropsychopharmacology; 2016 Sep; 41(10):2455-62. PubMed ID: 27000940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
